ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,044,550 | +305.6% | 295,000 | +293.3% | 1.99% | +304.1% |
| Q2 2023 | $1,490,250 | -53.0% | 75,000 | -62.5% | 0.49% | -28.5% |
| Q1 2022 | $3,172,000 | -65.8% | 200,000 | -52.9% | 0.69% | -79.3% |
| Q4 2021 | $9,278,000 | -11.3% | 425,000 | +21.4% | 3.32% | +8.7% |
| Q3 2021 | $10,462,000 | +89.0% | 350,000 | +180.0% | 3.06% | +101.0% |
| Q2 2021 | $5,536,000 | -61.6% | 125,000 | -61.5% | 1.52% | -55.1% |
| Q1 2021 | $14,420,000 | -47.4% | 325,000 | -35.0% | 3.39% | -44.5% |
| Q4 2020 | $27,420,000 | +199.9% | 500,000 | +25.0% | 6.11% | +131.2% |
| Q3 2020 | $9,144,000 | -32.8% | 400,000 | -38.5% | 2.64% | -26.4% |
| Q2 2020 | $13,605,000 | +50.0% | 650,000 | 0.0% | 3.59% | +49.2% |
| Q1 2020 | $9,068,000 | -43.1% | 650,000 | -7.1% | 2.40% | -20.7% |
| Q4 2019 | $15,932,000 | +118.8% | 700,000 | +12.0% | 3.03% | +63.6% |
| Q3 2019 | $7,281,000 | +5.5% | 625,000 | +35.9% | 1.86% | +29.6% |
| Q2 2019 | $6,900,000 | -34.4% | 460,000 | -23.3% | 1.43% | -48.0% |
| Q1 2019 | $10,524,000 | +18.4% | 600,000 | 0.0% | 2.75% | -14.8% |
| Q4 2018 | $8,892,000 | -9.7% | 600,000 | +50.0% | 3.23% | +54.2% |
| Q3 2018 | $9,848,000 | +43.3% | 400,000 | +14.3% | 2.09% | +3.5% |
| Q2 2018 | $6,871,000 | -56.9% | 350,000 | -58.8% | 2.02% | -37.3% |
| Q1 2018 | $15,938,000 | – | 850,000 | – | 3.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |